Respiratory-Related Quality of Life: Relation to Pulmonary Function, Functional Exercise Capacity, and Sputum Biophysical Properties
- 1 January 2000
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in Journal of Aerosol Medicine
- Vol. 13 (3) , 263-272
- https://doi.org/10.1089/jam.2000.13.263
Abstract
One of the difficulties in assessing mucoactive therapy is selecting clinical outcome variables that reflect the impact of clearing airway secretions on quality of life (QOL). Petty and colleagues developed a questionnaire designed to evaluate the clinical impact of mucoactive therapy in patients with chronic bronchitis (CB). We evaluated this questionnaire in a multicenter study of a mucolytic medication used in patients with CB and hypothesized that spirometry, exercise capacity, and sputum clearability changes would correlate with QOL changes. This was a multicenter trial in 159 patients with stable CB (111 completed the 16-week study). Spirometry, plethysmography, the 6-minute walk test (6MWT), and Petty score as a measure of QOL were assessed at each visit. Sputum was collected at each visit. Cough transportability was measured in a cough machine, and mucociliary transportability was measured on the frog palate. Cohesivity was measured in a filancemeter, interfacial tension by de Noüy ring, and wettability by contact angle analysis. Within the entire data set of 694 evaluations, there was no correlation between pulmonary function and QOL. There was an inverse correlation with distance covered in a 6MWT (R2 = 0.041, p < 0.0001). Sputum CTR was directly correlated with QOL (R2 = 0.027, p < 0.0001). Change from baseline (mean of first three visits) was computed and compared the change in the mean of values at the 8- and 12-week visits (n = 108 sets of data pairs). This was analyzed as a percentage of change for continuous measurements, and as QOL is normative, we calculated the absolute change in QOL. There was no relation between QOL and 6MWT changes. There was an inverse relation between change in forced expiratory volume in 1 second and QOL (R2 = 0.092, p = 0.0021) as well as between forced vital capacity and QOL (R2 = 0.05, p = 0.024). There was a direct relation between CTR and QOL (R2 = 0.039, p = 0.048). The relation between QOL and 6-minute walk distance was expected but weak. The consistent relation between CTR and QOL (suggesting that improved CTR of sputum is associated with decreased QOL) is difficult to explain. A change in forced expiratory volume in 1 second and forced vital capacity did correlate with a change in QOL. There is a need for a good QOL tool to evaluate mucus clearance devices or medications. The Petty questionnaire was designed specifically for this task, but the effect on sputum properties by current mucoactive agents may be too small to elicit a significant change in the Petty score.Keywords
This publication has 16 references indexed in Scilit:
- Exercise Rehabilitation and Chronic Obstructive Pulmonary Disease StageAmerican Journal of Respiratory and Critical Care Medicine, 1999
- An In Vitro Comparison of the Mucoactive Properties of Guaifenesin, Iodinated Glycerol, Surfactant, and AlbuterolChest, 1999
- Improvements in outcomes for chronic obstructive pulmonary disease (COPD) attributable to a hospital-based respiratory rehabilitation programmeAustralian and New Zealand Journal of Medicine, 1999
- Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patientsHeart, 1998
- Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients.American Journal of Respiratory and Critical Care Medicine, 1997
- Iodinated Glycerol Has No Effect on Pulmonary Function, Symptom Score, or Sputum Properties in Patients With Stable Chronic BronchitisChest, 1996
- The National Mucolytic StudyChest, 1990
- Mucus transport in a miniaturized simulated cough machine: Effect of constriction and serous layer simulantBiorheology, 1989
- A measure of quality of life for clinical trials in chronic lung disease.Thorax, 1987
- The Measurement of DyspneaChest, 1984